Connect
MJA
MJA

Guidelines for the management of acute coronary syndromes 2006

Mark Little and Chris Johnstone
Med J Aust 2007; 187 (6): 372.
Published online: 17 September 2007

To the Editor: The Guidelines for the management of acute coronary syndromes 20061 state: “Enoxaparin may be used in conjunction with fibrin-specific fibrinolytic agents in patients under the age of 75 years, provided they do not have significant renal dysfunction. An intravenous bolus dose of 30 mg followed by a 1 mg/kg subcutaneous injection every 12 hours in combination with tenecteplase is the most comprehensively studied therapy.”1

  • Mark Little
  • Chris Johnstone

  • Emergency Department, Caboolture Hospital, Caboolture, QLD.


Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.